Orthopediatrics (NASDAQ:KIDS) announced its quarterly earnings data on Wednesday, March 7th. The company reported ($4.35) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.13) by ($4.22), Bloomberg Earnings reports. The business had revenue of $11.68 million during the quarter, compared to analysts’ expectations of $11.45 million.
Orthopediatrics (KIDS) traded down $0.12 during trading hours on Wednesday, hitting $17.14. The stock had a trading volume of 31,238 shares, compared to its average volume of 41,163. Orthopediatrics has a 1-year low of $15.10 and a 1-year high of $23.00. The company has a debt-to-equity ratio of -0.38, a quick ratio of 1.00 and a current ratio of 2.78.
A number of brokerages have commented on KIDS. Zacks Investment Research lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. BidaskClub lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. Finally, BTIG Research restated a “buy” rating and issued a $24.00 price target on shares of Orthopediatrics in a research report on Friday, January 5th. Two investment analysts have rated the stock with a sell rating and four have given a buy rating to the company. Orthopediatrics presently has an average rating of “Hold” and an average price target of $23.67.
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.